| __timestamp | Dr. Reddy's Laboratories Limited | Evotec SE |
|---|---|---|
| Wednesday, January 1, 2014 | 38783000000 | 17990000 |
| Thursday, January 1, 2015 | 42585000000 | 25166000 |
| Friday, January 1, 2016 | 45702000000 | 27013000 |
| Sunday, January 1, 2017 | 46372000000 | 42383000 |
| Monday, January 1, 2018 | 46910000000 | 57012000 |
| Tuesday, January 1, 2019 | 48890000000 | 66546000 |
| Wednesday, January 1, 2020 | 50129000000 | 77238000 |
| Friday, January 1, 2021 | 54559000000 | 105445000 |
| Saturday, January 1, 2022 | 62081000000 | 156190000 |
| Sunday, January 1, 2023 | 105931000000 | 169610000 |
| Monday, January 1, 2024 | 77201000000 |
Unleashing the power of data
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Dr. Reddy's Laboratories Limited and Evotec SE, two giants in the industry, have shown contrasting approaches over the past decade. From 2014 to 2023, Dr. Reddy's Laboratories consistently reported higher SG&A expenses, peaking in 2023 with a staggering 106% increase from 2014. In contrast, Evotec SE maintained a more modest growth, with expenses rising by approximately 843% over the same period. This stark difference highlights Dr. Reddy's aggressive expansion strategy, while Evotec's leaner approach suggests a focus on efficiency. However, the data for 2024 is incomplete, leaving room for speculation on future trends. As the industry evolves, these strategies will play a pivotal role in shaping the financial health of these companies.
Breaking Down SG&A Expenses: Alnylam Pharmaceuticals, Inc. vs Dr. Reddy's Laboratories Limited
Breaking Down SG&A Expenses: Neurocrine Biosciences, Inc. vs Dr. Reddy's Laboratories Limited
SG&A Efficiency Analysis: Comparing Neurocrine Biosciences, Inc. and Evotec SE
Who Optimizes SG&A Costs Better? Dr. Reddy's Laboratories Limited or Exelixis, Inc.
Dr. Reddy's Laboratories Limited vs CRISPR Therapeutics AG: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Dr. Reddy's Laboratories Limited and Galapagos NV
SG&A Efficiency Analysis: Comparing Dr. Reddy's Laboratories Limited and Amphastar Pharmaceuticals, Inc.
Blueprint Medicines Corporation and Evotec SE: SG&A Spending Patterns Compared
Ionis Pharmaceuticals, Inc. vs Evotec SE: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Verona Pharma plc and Evotec SE
Breaking Down SG&A Expenses: HUTCHMED (China) Limited vs Evotec SE
Who Optimizes SG&A Costs Better? Evotec SE or MiMedx Group, Inc.